- Active not recruitingPHASE2
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
This study is testing a new medicine, GSK4527226, for people in the early stages of Alzheimer's disease. Researchers want to see if it's safe and helps improve or slow down symptoms compared to a dummy medicine.
For: Alzheimer's DiseaseUnited States · Argentina · Australia - RecruitingPHASE2
Open-label Extension Study in Participants With Early Alzheimer's Disease
This study is looking into a new medication called GSK4527226 for people with early Alzheimer's disease. It's an extension of an earlier study, meaning everyone in this new phase will receive the treatment. We're checking how safe and effective it is over the long term.
For: Alzheimer's DiseaseUnited States · Argentina · Australia